When it comes to mutations in APOE, the long-standing yet controversial view is that women carriers of the ε4 allele are at a greater risk for late-onset Alzheimer’s disease (AD) than their male counterparts. However, a new meta-analysis has challenged this theory.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.